Skip to main content

Table 2 Univariate logistic regression models predicting EULAR response and DAS28 ≤ 3.2 at week 24 after rituximab

From: A combination of cellular biomarkers predicts failure to respond to rituximab in rheumatoid arthritis: a 24-week observational study

Baseline variables

EULAR response

DAS28 ≤ 3.2

OR (95 % CI)

P value

OR (95 % CI)

P value

Leucocytesa

1.00 (1.00–1.00)

0. 926

1.00 (1.00–1.00)

0.892

LCa

0.91 (0.83–0.99)

0.030

0.97 (0.90–1.04)

0.420

Natural killer cellsa

0.93 (0.59–1.48)

0.766

0.85 (0.50–1.41)

0.524

B cellsa

0.48 (0.26–0.87)

0.015

0.79 (0.52–1.20)

0.274

T cellsa

0.90 (0.81–1.00)

0.050

0.98 (0.91–1.07)

0.692

CD4+ a

0.87 (0.76–0.99)

0.029

0.96 (0.86–1.08)

0.491

CD8+ a

0.94 (0.74–1.20)

0.607

1.061 (0.85–1.33)

0.640

  1. aAbsolute values, multiplied by 100. EULAR European League Against Rheumatism, DAS28 disease activity score in 28 joints, CI confidence interval, LC total lymphocyte count, OR odds ratio (indicated per 100 cells/μl increase)
  2. Significant P values are indicated in bold numbers